Phillips-Medisize, a Molex company, will have a major exhibiting and speaking presence at the 8th Annual InnoPack Pharma Confex, to be held 21-22 May in Mumbai. As an established global leader, Phillips-Medisize provides a wide range of custom drug delivery devices, connected health solutions and end-to-end manufacturing services to Asian, European and U.S. pharmaceutical companies and is actively expanding its footprint in India.
On Day 1 (May 21) at 12:30 p.m., Bill Welch, Chief Technology Officer, Phillips-Medisize, will speak to pharma companies on how to reach the market faster and expedite product development with proven technology accelerators for all types of infusion, injection and inhalation devices. His presentation - "Transforming Drug Delivery" - will explain how to gain a competitive edge with human-centered design for customizable and user-friendly devices along with technology solutions that support global commercialisation.
On Day 2 (May 22) at 10:30 a.m., Welch will moderate a panel discussion of cutting-edge packaging experts on the "Importance of Connected Devices in Improving Patient Experiences." This session will address the role of connected patient-use drug delivery devices in healthcare ecosystems.
Throughout InnoPack, Welch and other Phillips-Medisize executives will be at the company's booth -A6 - to discuss the latest breakthroughs in drug delivery and to demonstrate how its innovative connected health solutions and powerful analytics are helping to improve patient engagement and adherence. From device design, development and manufacturing to the company's award-winning, FDA registered Connected Health Platform (CHP), Phillips-Medisize is transforming drug delivery around the world.
"Our primary business focus is on complex, regulated drug delivery devices and connected health solutions," Welch said. "Together with our customers, we challenge and push the limits of product design and development to help transform the diagnosis and delivery of healthcare."
Phillips-Medisize will also participate in a Packaging Leaders Roundtable - new at this year's InnoPack - where top industry experts will deliberate critical areas of pharma packaging and drug delivery. The company's thought-leaders will discuss opportunities to advance pharma packaging in India today and in the future.
By creating its Global Innovation and Development (GID) center in Bangalore, Phillips-Medisize is committed to building a healthcare focused team within the well-established Molex capabilities already in place there. This will help us better support customers in the region as they work on developing more intelligent drug delivery solutions.
"The added focus on healthcare in our India-based office, hiring of a senior business development director and continued investment in staff demonstrates our dedication to providing the right expertise, solutions and services that make a difference to our valued customers and their patients. We are thrilled to participate for the second year at InnoPack and anticipate continued success in this promising market," added Matt Jennings, CEO and President of Phillips-Medisize.
